JAK1 and non-small cell lung carcinoma: The results showed that high JAK1 expression indicated a favourable prognosis in NSCLC (OS: HR, 0.62, 95% CI from 0.53 to 0.74, log-rank P < 0.001; PFS: HR, 0.65, 95% CI from 0.50 to 0.86, log-rank P = 0.002).